These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32715342)

  • 1. Pulmonary involvement in systemic sclerosis: exploring cellular, genetic and epigenetic mechanisms.
    Doskaliuk B; Zaiats L; Yatsyshyn R; Gerych P; Cherniuk N; Zimba O
    Rheumatol Int; 2020 Oct; 40(10):1555-1569. PubMed ID: 32715342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
    Jimenez SA; Piera-Velazquez S
    Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
    Khanna D; Tashkin DP; Denton CP; Renzoni EA; Desai SR; Varga J
    Am J Respir Crit Care Med; 2020 Mar; 201(6):650-660. PubMed ID: 31841044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease.
    Valenzi E; Bulik M; Tabib T; Morse C; Sembrat J; Trejo Bittar H; Rojas M; Lafyatis R
    Ann Rheum Dis; 2019 Oct; 78(10):1379-1387. PubMed ID: 31405848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
    Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
    Front Immunol; 2020; 11():1990. PubMed ID: 33013852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic predictors of systemic sclerosis-associated interstitial lung disease: a review of recent literature.
    Stock CJW; Renzoni EA
    Eur J Hum Genet; 2018 Jun; 26(6):765-777. PubMed ID: 29476163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis.
    Mouawad JE; Feghali-Bostwick C
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung disease.
    Yang MM; Lee S; Neely J; Hinchcliff M; Wolters PJ; Sirota M
    Front Immunol; 2024; 15():1326922. PubMed ID: 38348044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.
    Mendoza FA; Piera-Velazquez S; Farber JL; Feghali-Bostwick C; Jiménez SA
    Arthritis Rheumatol; 2016 Jan; 68(1):210-7. PubMed ID: 26360820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension complicating connective tissue disease.
    Lynch JP; Belperio JA; Saggar R; Fishbein MC; Saggar R
    Semin Respir Crit Care Med; 2013 Oct; 34(5):581-99. PubMed ID: 24037627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lung involvement in systemic sclerosis].
    Posa M; Stelle M; Lador F; Chizzolini C
    Rev Med Suisse; 2015 Apr; 11(469):802-6. PubMed ID: 26040160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating extracellular vesicles in the context of interstitial lung disease related to systemic sclerosis: A scoping literature review.
    De Lorenzis E; Rindone A; Di Donato S; Del Galdo F
    Autoimmun Rev; 2023 Sep; 22(9):103401. PubMed ID: 37482367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.
    Saketkoo LA; Frech T; Varjú C; Domsic R; Farrell J; Gordon JK; Mihai C; Sandorfi N; Shapiro L; Poole J; Volkmann ER; Lammi M; McAnally K; Alexanderson H; Pettersson H; Hant F; Kuwana M; Shah AA; Smith V; Hsu V; Kowal-Bielecka O; Assassi S; Cutolo M; Kayser C; Shanmugam VK; Vonk MC; Fligelstone K; Baldwin N; Connolly K; Ronnow A; Toth B; Suave M; Farrington S; Bernstein EJ; Crofford LJ; Czirják L; Jensen K; Hinchclif M; Hudson M; Lammi MR; Mansour J; Morgan ND; Mendoza F; Nikpour M; Pauling J; Riemekasten G; Russell AM; Scholand MB; Seigart E; Rodriguez-Reyna TS; Hummers L; Walker U; Steen V
    Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101707. PubMed ID: 34538573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after lung transplantation in systemic sclerosis. A systematic review.
    Khan IY; Singer LG; de Perrot M; Granton JT; Keshavjee S; Chau C; Kron A; Johnson SR
    Respir Med; 2013 Dec; 107(12):2081-7. PubMed ID: 24113572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity and features of frailty in systemic sclerosis-associated interstitial lung disease.
    Guler SA; Kwan JM; Winstone TA; Milne KM; Dunne JV; Wilcox PG; Ryerson CJ
    Respir Med; 2017 Aug; 129():1-7. PubMed ID: 28732817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
    Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
    Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.
    Antoniou KM; Margaritopoulos GA; Goh NS; Karagiannis K; Desai SR; Nicholson AG; Siafakas NM; Coghlan JG; Denton CP; Hansell DM; Wells AU
    Arthritis Rheumatol; 2016 Apr; 68(4):1004-12. PubMed ID: 26636545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Artery Dimensions as a Prognosticator of Transplant-Free Survival in Scleroderma Interstitial Lung Disease.
    Gleason JB; Patel KB; Hernandez F; Hadeh A; Highland KB; Rahaghi F; Mehta JP
    Lung; 2017 Aug; 195(4):403-409. PubMed ID: 28456874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.